Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Float Short %

3.98

Margin Of Safety %

-21

Put/Call OI Ratio

0.17

EPS Next Q Diff

-0.13

EPS Last/This Y

3.3

EPS This/Next Y

1.28

Price

277.35

Target Price

307.11

Analyst Recom

1.67

Performance Q

5.73

Relative Volume

0.69

Beta

0.51

Ticker: PEN




22 items of 1

DateSymbolLastP/C OIP/C VolTotal OI
2025-03-20PEN281.70.100.0010931
2025-03-21PEN280.50.100.0110934
2025-03-24PEN286.110.180.004265
2025-03-25PEN283.590.180.184256
2025-03-26PEN275.060.180.204289
2025-03-27PEN269.610.180.174297
2025-03-28PEN267.540.180.004310
2025-03-31PEN267.540.180.004314
2025-04-01PEN271.420.170.464502
2025-04-02PEN277.420.170.134515
2025-04-03PEN273.250.170.184535
2025-04-04PEN267.370.170.334556
2025-04-07PEN263.770.170.864565
2025-04-08PEN2560.170.074576
2025-04-09PEN275.040.170.174576
2025-04-10PEN268.820.173.004585
2025-04-11PEN272.20.170.054584
2025-04-14PEN270.210.170.144587
2025-04-15PEN271.990.170.224605
2025-04-16PEN278.070.170.084610
2025-04-17PEN277.350.170.014648
2025-04-18PEN277.350.170.014648
DateSymbolLastP/C OIP/C VolTotal OI
22 items Current Page1 of 1




22 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2025-03-20PEN281.3364.7165.03.66
2025-03-21PEN280.2964.7163.13.66
2025-03-24PEN286.2364.7167.73.66
2025-03-25PEN283.4264.7161.93.66
2025-03-26PEN275.1564.7158.33.66
2025-03-27PEN268.7364.7159.43.67
2025-03-28PEN267.5664.7162.43.67
2025-03-31PEN267.4164.7163.73.67
2025-04-01PEN271.1364.7166.43.67
2025-04-02PEN277.3564.7168.13.67
2025-04-03PEN273.2464.7161.03.67
2025-04-04PEN262.6963.0156.53.65
2025-04-07PEN263.8963.0164.93.65
2025-04-08PEN255.8263.0158.33.65
2025-04-09PEN275.4663.0178.33.65
2025-04-10PEN268.6563.0159.13.65
2025-04-11PEN272.3963.0166.53.65
2025-04-14PEN270.2763.0162.43.65
2025-04-15PEN272.2662.2165.23.65
2025-04-16PEN277.9562.2167.73.65
2025-04-17PEN277.3562.7163.53.66
2025-04-18PEN277.3562.7163.83.66
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
22 items Current Page1 of 1




22 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2025-03-20PEN-10.00-1.043.65
2025-03-21PEN-10.00-1.043.65
2025-03-24PEN-10.99-1.123.65
2025-03-25PEN-10.10-1.123.65
2025-03-26PEN-10.10-1.123.29
2025-03-27PEN-10.10-1.123.29
2025-03-28PEN-10.82-1.123.29
2025-03-31PEN-10.73-1.123.30
2025-04-01PEN-10.73-1.123.29
2025-04-02PEN-10.82-1.123.29
2025-04-03PEN-10.89-1.123.29
2025-04-04PEN-10.83-1.123.29
2025-04-07PEN-11.82-1.123.29
2025-04-08PEN-11.82-1.123.29
2025-04-09PEN-11.82-1.123.29
2025-04-10PEN-11.78-1.123.99
2025-04-11PEN-11.78-1.123.98
2025-04-14PEN-11.60-1.133.98
2025-04-15PEN-11.60-1.133.98
2025-04-16PEN-11.60-1.133.98
2025-04-17PEN-11.60-1.133.98
2025-04-18PEN-11.60-1.133.98
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
22 items Current Page1 of 1

Last Quarter Act. EPS

0.97

Avg. EPS Est. Current Quarter

0.68

Avg. EPS Est. Next Quarter

0.84

Insider Transactions

-11.6

Institutional Transactions

-1.13

Beta

0.51

Average Sales Estimate Current Quarter

315

Average Sales Estimate Next Quarter

332

Fair Value

218.79

Quality Score

75

Growth Score

81

Sentiment Score

95

Actual DrawDown %

20.5

Max Drawdown 5-Year %

-62.6

Target Price

307.11

P/E

806.25

Forward P/E

56.08

PEG

19.88

P/S

8.98

P/B

9.28

P/Free Cash Flow

72.84

EPS

0.34

Average EPS Est. Cur. Y​

3.66

EPS Next Y. (Est.)

4.94

Target Price Estimates Raised

1

Target Price Estimates Lowered

Profit Margin

1.17

Relative Volume

0.69

Return on Equity vs Sector %

-18.8

Return on Equity vs Industry %

-17

EPS 1 7Days Diff

EPS 1 30Days Diff

-0.01

EBIT Estimation

163.8
Penumbra, Inc.
Sector: Healthcare
Industry: Medical Devices
Employees: 4500
Penumbra, Inc., together with its subsidiaries, designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers peripheral thrombectomy products, including the Indigo System for power aspiration of thrombus in the body; Lightning Flash, a mechanical thrombectomy system; Lightning Bolt 7, an arterial thrombectomy system; and CAT RX. It also provides access products, including guide catheters and the Penumbra distal delivery catheters under the Neuron, Neuron MAX, BENCHMARK, BMX, DDC, MIDWAY, and PX SLIM brands; Penumbra System, an integrated mechanical thrombectomy system comprising reperfusion catheters and separators, the 3D Revascularization device, aspiration tubing, and aspiration pump under the Penumbra RED, SENDit, JET, ACE, BMX, Max, 3D Revascularization Device, and Penumbra ENGINE brands; and neuro embolization coiling systems that includes the Penumbra Coil 400, a detachable coil that provides an alternative for the treatment of aneurysms and other complex lesions, as well as detachable coils to treat patients with a wide range of neurovascular lesions under the Penumbra SMART COIL and Penumbra SwiftPAC Coil brands; and POD400 and PAC400 brands. In addition, the company provides peripheral embolization products, such as Ruby Coil System consisting of detachable coils for peripheral applications; Penumbra LANTERN Delivery Microcatheter, a low-profile microcatheter with a high-flow lumen; POD (Penumbra Occlusion Device) System, a single device solution; and Packing Coil, a complementary device for use in other peripheral embolization products. Further, it offers neurosurgical tools comprising Artemis Neuro Evacuation Device for surgical removal of fluid and tissue from the ventricles and cerebrum. The company sells its products through direct sales organizations and distributors. Penumbra, Inc. was incorporated in 2004 and is headquartered in Alameda, California.
stock quote shares PEN – Penumbra, Inc. Stock Price stock today
news today PEN – Penumbra, Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch PEN – Penumbra, Inc. yahoo finance google finance
stock history PEN – Penumbra, Inc. invest stock market
stock prices PEN premarket after hours
ticker PEN fair value insiders trading